Louise Rodino-Klapac

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Cristin L. Rothfuss, as Attorney-in-Fact for Louise Rodino-Klapac
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Louise Rodino-Klapac:

Company Role Class Num Shares Value Price $ Report Date Ownership
Sarepta Therapeutics, Inc. President, R&D and Tech Ops Common Stock 226,271 $4,186,013 $18.50 09 Mar 2026 Direct
Sarepta Therapeutics, Inc. President, R&D and Tech Ops Performance Stock Units 0 $0 $100.13 01 Mar 2026 Direct
Sarepta Therapeutics, Inc. President, R&D and Tech Ops Stock Options (right to buy) 16,644 10 Mar 2025 Direct

Insider Reports Filed by Louise Rodino-Klapac

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SRPT Sarepta Therapeutics, Inc. 09 Mar 2026 2 $0 4 President, R&D and Tech Ops 11 Mar 2026, 20:04
SRPT Sarepta Therapeutics, Inc. 01 Mar 2026 4 -$72,657 4 President, R&D and Tech Ops 03 Mar 2026, 20:02
SRPT Sarepta Therapeutics, Inc. 25 Feb 2026 1 $0 4 President, R&D and Tech Ops 27 Feb 2026, 20:03
SRPT Sarepta Therapeutics, Inc. 17 Nov 2025 1 -$84,400 4 President, R&D and Tech Ops 19 Nov 2025, 20:05
SRPT Sarepta Therapeutics, Inc. 03 Sep 2025 2 $0 4 President, R&D and Tech Ops 05 Sep 2025, 21:30
SRPT Sarepta Therapeutics, Inc. 05 Aug 2025 1 $0 4 President, R&D and Tech Ops 06 Aug 2025, 20:01
SRPT Sarepta Therapeutics, Inc. 07 Mar 2025 6 -$346,750 4 Head of R&D, CSO 11 Mar 2025, 20:00
SRPT Sarepta Therapeutics, Inc. 06 Mar 2025 4 -$881,865 4 Head of R&D, CSO 10 Mar 2025, 20:00
SRPT Sarepta Therapeutics, Inc. 04 Mar 2025 1 -$172,683 4 Head of R&D, CSO 06 Mar 2025, 20:00
SRPT Sarepta Therapeutics, Inc. 03 Mar 2025 1 -$74,196 4 Head of R&D, CSO 04 Mar 2025, 20:00
SRPT Sarepta Therapeutics, Inc. 11 Feb 2025 1 $0 4 Head of R&D, CSO 13 Feb 2025, 20:00
SRPT Sarepta Therapeutics, Inc. 18 Nov 2024 1 -$468,973 4 Head of R&D, CSO 20 Nov 2024, 20:00
SRPT Sarepta Therapeutics, Inc. 21 Jun 2024 5 -$359,244 4 Head of R&D, CSO 25 Jun 2024, 20:00
SRPT Sarepta Therapeutics, Inc. 07 Mar 2024 2 -$173,625 4 Head of R&D, CSO 11 Mar 2024, 20:00
SRPT Sarepta Therapeutics, Inc. 04 Mar 2024 1 -$216,553 4 Head of R&D, CSO 06 Mar 2024, 20:00
SRPT Sarepta Therapeutics, Inc. 01 Mar 2024 3 -$98,176 4 Head of R&D, CSO 05 Mar 2024, 20:00
SRPT Sarepta Therapeutics, Inc. 17 Nov 2023 1 -$374,074 4 Head of R&D, CSO 20 Nov 2023, 20:00
SRPT Sarepta Therapeutics, Inc. 08 Mar 2023 1 -$139,709 4 Head of R&D, CSO 10 Mar 2023, 19:00
SRPT Sarepta Therapeutics, Inc. 06 Mar 2023 3 -$178,276 4 Head of R&D, CSO 08 Mar 2023, 19:00
SRPT Sarepta Therapeutics, Inc. 01 Mar 2023 1 -$77,032 4 Head of R&D, CSO 03 Mar 2023, 19:00
SRPT Sarepta Therapeutics, Inc. 17 Nov 2022 1 -$456,978 4 Head of R&D, CSO 21 Nov 2022, 19:02
SRPT Sarepta Therapeutics, Inc. 04 Mar 2022 3 -$96,307 4 Head of R&D, CSO 08 Mar 2022, 19:00
SRPT Sarepta Therapeutics, Inc. 01 Mar 2022 1 -$42,929 4 Head of R&D, CSO 01 Mar 2022, 19:03
SRPT Sarepta Therapeutics, Inc. 24 Nov 2021 1 +$299,867 4 Head of R&D, CSO 29 Nov 2021, 07:00
SRPT Sarepta Therapeutics, Inc. 16 Nov 2021 1 $0 4 Chief Scientific Officer 17 Nov 2021, 19:03